Finance

Beta
Lists
NSRX:NYSEAMERICAN
Nasus Pharma Ltd
$3.35
-1.47%
(-0.050) 1D
$3.40
+2.41% (+0.08)
Pre-market
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NSRX...
Open
$3.35
High
$3.35
Low
$3.35
Mkt. cap
39.23M
Avg. vol.
40.97K
Volume
596.00
52-wk high
$9.99
52-wk low
$1.98
EPS
-$1.45
Shares outstanding
11.71M
No. of employees
7
Open
$3.35
High
$3.35
Low
$3.35
Mkt. cap
39.23M
Avg. vol.
40.97K
Volume
596.00
52-wk high
$9.99
52-wk low
$1.98
EPS
-$1.45
Shares outstanding
11.71M
No. of employees
7
News stories
From sources across the web
About Nasus Pharma Ltd
CEO-
Employees7
Founded2019
Headquarters-
SectorPharmaceutical industry
Websitenasuspharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
144.50K
144.50K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
264.00K
264.00K
-
-
Operating expense
408.50K
408.50K
-
-
Total operating expenses
408.50K
408.50K
-
-
Operating income
-408.50K
-408.50K
-
-
Other non operating income
-25.50K
-25.50K
-
-
EBT including unusual items
-597.00K
-597.00K
-
-
EBT excluding unusual items
-434.00K
-434.00K
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-626.00K
-626.00K
-
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of NSRX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer